planet labs pbc - PL
PL
Close Chg Chg %
27.89 0.06 0.23%
Pre-Market
27.95
+0.06 (0.23%)
Volume: 18.97M
Last Updated:
Mar 31, 2026, 3:59 PM EDT
Company Overview: planet labs pbc - PL
PL Key Data
| Open $28.71 | Day Range 26.29 - 28.93 |
| 52 Week Range 2.79 - 37.05 | Market Cap $9.65B |
| Shares Outstanding 346.15M | Public Float 264.18M |
| Beta 1.96 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.79 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 16.84M |
PL Performance
| 1 Week | -9.43% | ||
| 1 Month | 15.78% | ||
| 3 Months | 41.73% | ||
| 1 Year | 781.70% | ||
| 5 Years | N/A |
PL Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
12
Full Ratings ➔
About planet labs pbc - PL
Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.
PL At a Glance
Planet Labs PBC
645 Harrison Street
San Francisco, California 94107
| Phone | 1-415-829-3313 | Revenue | 307.73M | |
| Industry | Packaged Software | Net Income | -246,860,000.00 | |
| Sector | Technology Services | 2026 Sales Growth | 25.936% | |
| Fiscal Year-end | 01 / 2027 | Employees | 1,000 | |
| View SEC Filings |
PL Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 24.976 |
| Price to Book Ratio | 44.437 |
| Price to Cash Flow Ratio | 57.20 |
| Enterprise Value to EBITDA | -142.287 |
| Enterprise Value to Sales | 24.397 |
| Total Debt to Enterprise Value | 0.062 |
PL Efficiency
| Revenue/Employee | 307,727.00 |
| Income Per Employee | -246,860.00 |
| Receivables Turnover | 3.684 |
| Total Asset Turnover | 0.346 |
PL Liquidity
| Current Ratio | 1.648 |
| Quick Ratio | 1.635 |
| Cash Ratio | 1.365 |
PL Profitability
| Gross Margin | 56.056 |
| Operating Margin | -30.738 |
| Pretax Margin | -78.708 |
| Net Margin | -80.22 |
| Return on Assets | -27.745 |
| Return on Equity | -78.403 |
| Return on Total Capital | -37.925 |
| Return on Invested Capital | -44.994 |
PL Capital Structure
| Total Debt to Total Equity | 245.437 |
| Total Debt to Total Capital | 71.051 |
| Total Debt to Total Assets | 40.367 |
| Long-Term Debt to Equity | 241.565 |
| Long-Term Debt to Total Capital | 69.93 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Planet Labs Pbc - PL
Collapse All in section
| All values USD millions. | 2023 | 2024 | 2025 | 2026 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 191.26M | 220.70M | 244.35M | 307.73M | |
Sales Growth
| +45.76% | +15.39% | +10.72% | +25.94% | |
Cost of Goods Sold (COGS) incl D&A
| 97.25M | 107.75M | 103.31M | 135.23M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 43.33M | 47.64M | 45.64M | 41.83M | |
Depreciation
| 38.03M | 41.14M | 37.34M | 32.52M | |
Amortization of Intangibles
| 5.30M | 6.50M | 8.30M | 9.30M | |
COGS Growth
| +17.18% | +10.80% | -4.12% | +30.90% | |
Gross Income
| 94.01M | 112.95M | 141.05M | 172.50M | |
Gross Income Growth
| +94.95% | +20.15% | +24.88% | +22.30% | |
Gross Profit Margin
| +49.15% | +51.18% | +57.72% | +56.06% |
| 2023 | 2024 | 2025 | 2026 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 269.68M | 282.70M | 242.36M | 267.09M | |
Research & Development
| 110.92M | 116.34M | 96.68M | 106.56M | |
Other SG&A
| 158.77M | 166.36M | 145.68M | 160.53M | |
SGA Growth
| +52.99% | +4.83% | -14.27% | +10.20% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| (6.55M) | (13.71M) | 29.93M | 167.57M | |
EBIT after Unusual Expense
| (169.12M) | (156.04M) | (131.24M) | (262.16M) | |
Non Operating Income/Expense
| 8.00M | 16.34M | 10.50M | 23.39M | |
Non-Operating Interest Income
| 7.67M | 15.41M | 10.26M | 14.33M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| - | - | - | 3.44M | - |
Interest Expense Growth
| - | - | - | -100.00% | - |
Gross Interest Expense
| - | - | - | 3.44M | - |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (161.12M) | (139.69M) | (120.74M) | (242.21M) | |
Pretax Income Growth
| -19.34% | +13.30% | +13.57% | -100.61% | |
Pretax Margin
| -84.24% | -63.30% | -49.41% | -78.71% | |
Income Tax
| 847.00K | 815.00K | 2.46M | 4.66M | |
Income Tax - Current - Domestic
| 45.00K | 36.00K | 54.00K | 80.00K | |
Income Tax - Current - Foreign
| 1.26M | 631.00K | 2.31M | 4.52M | |
Income Tax - Deferred - Domestic
| (673.00K) | 134.00K | 73.00K | 53.00K | |
Income Tax - Deferred - Foreign
| 217.00K | 14.00K | 25.00K | 3.00K | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (161.97M) | (140.51M) | (123.20M) | (246.86M) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (161.97M) | (140.51M) | (123.20M) | (246.86M) | |
Net Income Growth
| -18.12% | +13.25% | +12.32% | -100.38% | |
Net Margin Growth
| -84.69% | -63.67% | -50.42% | -80.22% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (161.97M) | (140.51M) | (123.20M) | (246.86M) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (161.97M) | (140.51M) | (123.20M) | (246.86M) | |
EPS (Basic)
| -0.6063 | -0.5026 | -0.4217 | -0.802 | |
EPS (Basic) Growth
| -16.19% | +17.10% | +16.10% | -90.18% | |
Basic Shares Outstanding
| 267.13M | 279.59M | 292.12M | 307.80M | |
EPS (Diluted)
| -0.6063 | -0.5026 | -0.4217 | -0.802 | |
EPS (Diluted) Growth
| -16.19% | +17.10% | +16.10% | -90.18% | |
Diluted Shares Outstanding
| 267.13M | 279.59M | 292.12M | 307.80M | |
EBITDA
| (132.34M) | (122.11M) | (55.67M) | (52.76M) | |
EBITDA Growth
| -59.55% | +7.73% | +54.41% | +5.23% | |
EBITDA Margin
| -69.20% | -55.33% | -22.78% | -17.15% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 34.182 | |
| Number of Ratings | 12 | Current Quarters Estimate | -0.038 | |
| FY Report Date | 04 / 2026 | Current Year's Estimate | -0.11 | |
| Last Quarter’s Earnings | N/A | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -0.04 | Next Fiscal Year Estimate | 0.002 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 9 | 9 | 10 | 9 |
| Mean Estimate | -0.04 | -0.03 | -0.11 | 0.00 |
| High Estimates | 0.00 | 0.01 | 0.06 | 0.15 |
| Low Estimate | -0.07 | -0.05 | -0.28 | -0.12 |
| Coefficient of Variance | -49.53 | -67.64 | -80.48 | 4,142.23 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 8 | 8 | 8 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 3 | 3 | 3 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Planet Labs Pbc - PL
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Planet Labs Pbc - PL
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Feb 6, 2026 | Robert H. Schingler Co-Founder Chief Strategy Off.; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 6, 2026 | Carl Bass Director | 397,186 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 6, 2026 | Carl Bass Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 6, 2026 | Robert H. Schingler Co-Founder Chief Strategy Off.; Director | 911,558 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $23.95 per share | 21,831,814.10 |
| Feb 6, 2026 | Ita M. Brennan Director | 300,658 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 6, 2026 | Ita M. Brennan Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 6, 2026 | Ashley Whitfield Fieglein Johnson President & CFO | 2,017,418 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 6, 2026 | Ashley Whitfield Fieglein Johnson President & CFO | 1,983,724 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $23.95 per share | 47,510,189.80 |
| Feb 6, 2026 | Ashley Whitfield Fieglein Johnson President & CFO | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 6, 2026 | William S. Marshall Co-Founder and CEO; Director | 3,146,520 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 6, 2026 | William S. Marshall Co-Founder and CEO; Director | 3,083,479 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $23.95 per share | 73,849,322.05 |
| Feb 6, 2026 | William S. Marshall Co-Founder and CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 6, 2026 | Robert H. Schingler Co-Founder Chief Strategy Off.; Director | 930,062 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jul 11, 2025 | John W Raymond Director | 43,608 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 11, 2025 | Kristen O. Robinson Director | 298,562 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 11, 2025 | Vijaya Venkata Gadde Director | 270,169 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 11, 2025 | Gary B. Smith Director | 32,468 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 11, 2025 | Kristen O. Robinson Director | 307,839 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |